Read + Share
Mao YY, Cai HC, Shen KN, Chang L, et al. Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a
prospective phase 2 study. Ann Hematol 2022 Jan 17. pii: 10.1007/s00277-022-04764.
PMID: 35039900
|
 |
|
Mao YY, Cai HC, Shen KN, Chang L, et al. Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a
prospective phase 2 study. Ann Hematol 2022 Jan 17. pii: 10.1007/s00277-022-04764.
PMID: 35039900
|
|
|
|